Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00236223
Status:
TERMINATED
Last Update Posted:
2008-05-15
First Post:
2005-10-07
Brief Title:
The Effect of Gabapentin Ketamine and Dexamethasone on Pain and Opioid Requirements After Hip Surgery
Sponsor:
Glostrup University Hospital Copenhagen
Organization:
Glostrup University Hospital Copenhagen
Study Overview
Official Title:
The Effect of Gabapentin Low Dose Ketamine Paracetamol NSAID and Dexamethasone on Pain and Opioid Requirements in Patients Scheduled for Primary Total Hip Replacement
Status:
TERMINATED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Structural changes that stopped the type of operations used in the study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients scheduled for primary hip replacement needs postoperative pain treatment ie morphine Morphine has side-effects nausea vomiting sedation and dizziness These side-effects are unpleasant for the patients and sometimes keeps them at bed longer time than needed We investigate in new combinations of analgesics for postoperative pain hoping to minimize the need for morphine
Detailed Description:
The effect on postoperative pain of the combination of preoperative gabapentin 1200 mg dexamethasone 8 mg ketamine 015mgkg versus placebo is investigated on patients having a hip alloplastic operation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None